Lutrelef (gonadorelin acetate) / Ferring - LARVOL DELTA

A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump (clinicaltrials.gov) - P1 | N=0 | Withdrawn | Sponsor: Ferring Pharmaceuticals | N=180 ➔ 0 | Trial completion date: Jan 2026 ➔ Oct 2025 | Recruiting ➔ Withdrawn | Trial primary completion date: Jan 2026 ➔ Oct 2025

Enrollment change • Trial completion date • Trial primary completion date • Trial withdrawal • Infertility • Sexual Disorders • Women's Health

A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump (clinicaltrials.gov) - P1 | N=180 | Recruiting | Sponsor: Ferring Pharmaceuticals | Not yet recruiting ➔ Recruiting

Enrollment open • Infertility • Sexual Disorders • Women's Health

Hormonal Mechanisms of Sleep Restriction - Axis Study (clinicaltrials.gov) - P1 | N=80 | Active, not recruiting | Sponsor: Peter y. Liu | Trial completion date: Mar 2025 ➔ Jun 2026

Trial completion date

Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women (clinicaltrials.gov) - P1 | N=5 | Active, not recruiting | Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Trial completion date: Jul 2024 ➔ Jun 2026

Trial completion date

A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump (clinicaltrials.gov) - P1 | N=180 | Not yet recruiting | Sponsor: Ferring Pharmaceuticals

New P1 trial • Infertility • Sexual Disorders • Women's Health

Hormonal Mechanisms of Sleep Restriction - Axis Study (clinicaltrials.gov) - P1 | N=80 | Active, not recruiting | Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Trial completion date: Dec 2024 ➔ Mar 2025

Trial completion date

Lutre-UP: GnRH Therapy on Cognition in Down Syndrome (clinicaltrials.gov) - P2/3 | N=56 | Recruiting | Sponsor: Nelly Pitteloud | Active, not recruiting ➔ Recruiting

Enrollment open • Alzheimer's Disease • CNS Disorders • Developmental Disorders • Genetic Disorders

Hormonal Mechanisms of Sleep Restriction - Axis Study (clinicaltrials.gov) - P1 | N=80 | Active, not recruiting | Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Trial completion date: Dec 2023 ➔ Dec 2024

Trial completion date

Lutre-UP: GnRH Therapy on Cognition in Down Syndrome (clinicaltrials.gov) - P2/3 | N=56 | Active, not recruiting | Sponsor: Nelly Pitteloud | Phase classification: P2 ➔ P2/3 | N=32 ➔ 56 | Trial completion date: Mar 2024 ➔ Dec 2028 | Trial primary completion date: Dec 2023 ➔ Dec 2028

Enrollment change • Phase classification • Trial completion date • Trial primary completion date • Alzheimer's Disease • CNS Disorders • Developmental Disorders • Genetic Disorders

Hormonal Mechanisms of Sleep Restriction - Axis Study (clinicaltrials.gov) - P1 | N=80 | Active, not recruiting | Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Trial completion date: Dec 2022 ➔ Dec 2023

Trial completion date

Lutre-UP: GnRH Therapy on Cognition in Down Syndrome (clinicaltrials.gov) - P2 | N=32 | Active, not recruiting | Sponsor: Nelly Pitteloud | Recruiting ➔ Active, not recruiting

Enrollment closed • Alzheimer's Disease • CNS Disorders • Developmental Disorders • Genetic Disorders

Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women (clinicaltrials.gov) - P1 | N=5 | Active, not recruiting | Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Recruiting ➔ Active, not recruiting | N=40 ➔ 5 | Trial completion date: Jul 2023 ➔ Jul 2024

Enrollment change • Enrollment closed • Trial completion date

Hormonal Mechanisms of Sleep Restriction - Axis Study (clinicaltrials.gov) - P1 | N=80 | Active, not recruiting | Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Trial completion date: Sep 2022 ➔ Dec 2022

Trial completion date

Lutre-UP: GnRH Therapy on Cognition in Down Syndrome (clinicaltrials.gov) - P2 | N=32 | Recruiting | Sponsor: Nelly Pitteloud | Phase classification: P=N/A ➔ P2

Phase classification • Alzheimer's Disease • CNS Disorders • Developmental Disorders • Genetic Disorders

Hormonal Mechanisms of Sleep Restriction - Axis Study (clinicaltrials.gov) - P1; N=80; Active, not recruiting; Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Recruiting ➔ Active, not recruiting; Trial primary completion date: Sep 2022 ➔ Oct 2020

Enrollment closed • Trial primary completion date

Lutre-UP: GnRH Therapy on Cognition in Down Syndrome (clinicaltrials.gov) - P=N/A; N=32; Recruiting; Sponsor: Nelly Pitteloud; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Alzheimer's Disease • CNS Disorders • Developmental Disorders • Genetic Disorders

Lutre-UP: GnRH Therapy on Cognition in Down Syndrome (clinicaltrials.gov) - P=N/A; N=32; Not yet recruiting; Sponsor: Nelly Pitteloud; Initiation date: Jun 2020 ➔ Sep 2020

Clinical • Trial initiation date • Alzheimer's Disease • CNS Disorders • Developmental Disorders • Genetic Disorders • MRI

Lutre-UP: GnRH Therapy on Cognition in Down Syndrome (clinicaltrials.gov) - P=N/A; N=32; Not yet recruiting; Sponsor: Nelly Pitteloud

Clinical • New trial • Alzheimer's Disease • CNS Disorders • Developmental Disorders • Genetic Disorders • MRI

LutrePulse Hypogonadotropic Hypogonadism (clinicaltrials.gov) - P3; N=60; Recruiting; Sponsor: Ferring Pharmaceuticals; Trial primary completion date: Apr 2016 ➔ Apr 2017

Trial primary completion date • Biosimilar